Logo
F

Farallon Capital Management

279 employees

Farallon Capital Management operates as a global institutional asset management firm.

Investor insights

Sectors invested in

Biotechnology32
Health Care30
Medical Device11
Health Diagnostics10
Therapeutics9
Pharmaceutical8
Life Science7
Medical7
Genetics6
Photography4
Media and Entertainment4
Video4
Broadcasting4
Diabetes3
Information Technology3
Transportation3
Biopharma3
the iLet Bionic Pancreas3
Technology3
Artificial Intelligence3

Funding rounds participated in

$100M sweet spot round size

Most of their 56 investments are in rounds between $40M and $165M

Investor type

Private Equity Firm
Venture Capital

Basic info

Industry

investment management

Sectors

Photography
Financial Services
Finance

Date founded

1986

Investments made

B

Beta Bionics raised $100M on August 30, 2023

Investors: Sands Capital Management, Pura Vida Investments, Perceptive Advisors, Marshall Wace, RTW Investments, LP, Soleus Capital Management, L.P., Eventide Asset Management, LifeSci Venture Partners, Omega Funds and Farallon Capital Management

M

MediciNova, Inc. raised $25M on August 1, 2023

Investors: Perceptive Advisors, - and Farallon Capital Management

A

Auna raised $505M on March 29, 2023

Investors: Lumia Capital, Enfoca and Farallon Capital Management

F

FogPharma raised $178M on November 21, 2022

Investors: T. Rowe Price, GV, The Invus Group, venBio Partners and Farallon Capital Management

G

GreenYellow raised $124M on February 21, 2022

Investors: Farallon Capital Management

B

Beta Bionics raised $57M on February 17, 2022

Investors: Soleus Capital Management, L.P., Pura Vida Investments, Novo Nordisk Ltd, LifeSci Venture Partners, Eventide Asset Management, RTW Investments, LP, Perceptive Advisors and Farallon Capital Management

A

Ada Health raised $30M on February 10, 2022

Investors: Red River West, Bertelsmann SE & Co. KGaA and Farallon Capital Management

B

Better Therapeutics raised $70M on October 29, 2021

Investors: Sectoral Asset Management, Monashee Investment Management LLC and Farallon Capital Management

D

DNA Script raised $165M on October 26, 2021

Investors: Illumina Ventures, Columbia Threadneedle Investments EMEA APAC, M Ventures, EQT Life Sciences, Coatue Management and Farallon Capital Management

I

InBrace raised $102M on September 8, 2021

Investors: Marshall Wace, Endeavour Vision, Vivo Capital, venBio Partners, MVM Partners, Soleus Capital Management, L.P., RTW Investments, LP and Farallon Capital Management

FAQ